• Explore /
  • Poster
  • / FDG PET-CT imaging in assessing interim response to neoadjuvant cisplatin-based chemotherapy (NAC) in muscle invasive bladder cancer (MIBC): A prospective study.

FDG PET-CT imaging in assessing interim response to neoadjuvant cisplatin-based chemotherapy (NAC) in muscle invasive bladder cancer (MIBC): A prospective study.

Abstract Poster

Authors

null

Srikala S. Sridhar

Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada

Srikala S. Sridhar , Nicholas Power , Rodney H. Breau , Susanna Y. Cheng , Gregory Russell Pond , Peter W. M. Chung , Ur Metser , Mark Norman Levine , Som D. Mukherjee

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer - Advanced

Sub Track

Diagnostics and Imaging

Clinical Trial Registration Number

NCT02462239

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 460)

DOI

10.1200/JCO.2023.41.6_suppl.460

Abstract #

460

Poster Bd #

G20

Abstract Disclosures

Similar Posters

First Author: Benjamin Miron

First Author: Yongjune Lee

First Author: Hiroshi Kitamura

First Author: Ali Raza Khaki